# Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant

> **NCT01164514** · PHASE1 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 20 (actual)

## Conditions studied

- Bacterial Sepsis

## Interventions

- **BIOLOGICAL:** CPG 7909
- **BIOLOGICAL:** J5-OMP Vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01164514
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164514, "Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01164514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*